NEW YORK, July 26 (GenomeWeb News) - Bristol-Myers Squibb has taken a multi-year license to Ingenuity's Pathways Analysis and Pathways Knowledge Base applications, Ingenuity said today.
Under the agreement, Ingenuity Pathways Analysis will be available to all BMS scientists. Both Ingenuity products will be integrated with existing bioinformatics solutions at the drug company.
Ingenuity's Pathways Knowledge Base is a curated database of modeled relationships between proteins, genes, complexes, cells, tissues, drugs, and diseases. The Pathways Analysis application analyzes these relationships.